Why the study?
Does Qiliqiangxin therapy attenuate cardiac remodeling in a rat model of myocardial infarction?
Does Qiliqiangxin therapy attenuate cardiac remodeling in a rat model of myocardial infarction?
Qiliqiangxin therapy attenuates cardiac remodeling, preserves cardiac function, and reduces inflammation and fibrosis in a rat model of myocardial infarction.
QL may attenuate post-MI remodeling in rats; hypothesis-generating and should not yet change practice.
QL therapy exerted protective effects against cardiac remodeling potentially by inhibiting TGF-β1/Smad3 and NF-κB signaling pathways, thereby preserving cardiac function, as well as reducing myocardial inflammation and fibrosis.
No takes yet. Share an insight, caveat, or question.
Han et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: